Amplify Seymour Cannabis ETF (ARCA: CNBS)

Amplify Seymour Cannabis ETF (ARCA:CNBS), Quote.Headers.trade-ideas

Healthcare

Technology

Real Estate

Consumer Cyclical

Consumer Defensive

Industrials

In order to be eligible for investment in the Funds portfolio, securities must have adequate constituent liquidity and accessibility for an exchange-listed product, as determined by the Adviser, and must generally comply with the following liquidity standards a security must be listed on a regulated, major stock exchange in the form of shares tradeable for non-U.S. investors without restrictions; for U.S. based equity securities, 90% of the U.S. based equity weight must be in companies with a market capitalization of at least $75,000,000; and a non-U.S. equity security must have a market capitalization of at least $100,000,000; and for U.S. based equity securities, at least 70% of the equity weight must have either: (i) a monthly trading volume of at least 250,000, or (ii) an average notional value of monthly trades of at least $25,000,000 over the prior six months; and all non-U.S. equity securities must have either: (i) a monthly trading volume of at least 250,000, or (ii) an average notional value of monthly trades of at least $25,000,000 over the prior six months.

Curaleaf Holdings Inc.

Invesco Government & Agency Portfolio, Institutional Class

Innovative Industrial Proper Reit

Wm Technology Inc

Amplify Seymour Cannabis ETF

AI Generated Image 

Cannabis

Government

News

Penny Stocks

Regulations

Emerging Markets

Politics

Small Cap

Markets

General

AYRWF

CCHWF

CNBS

CRLBF

CURALEAF HLDGS INC by Curaleaf Hldgs Inc.

CURLF

GTBIF

JUSHI HLDGS INC CL B by Jushi Holdings Inc.

JUSHF

TCNNF

TILT

TRSSF

VRNOF

Pennsylvania&#39;s recent budget approval excludes the legalization of recreational cannabis, marking a significant setback for cannabis companies like Jushi Holdings (OTC: JUSHF) and TILT Holdings (OTC: TILT).

These Two Cannabis Stocks Face Setback Following Pennsylvania Budget Approval: What You Need To Know

Analyst Color

Emerging Market ETFs

Management

Exclusives

Analyst Ratings

Trading Ideas

Interview

ETFs

Tim Seymour, portfolio manager of the $CNBS Amplify Seymour Cannabis ETF (NYSE: CNBS), is renowned for recognizing the potential of the cannabis sector early on.

Tim Seymour On Running A Cannabis Fund: &#39;We Focus On Companies Poised For Growth&#39;

cannabis USD BZCCC (Yeti studio and ImageFlow on Shutterstock)(3)

THE CANNABIST CO HLDG by THE CANNABIST COMPANY HOLDINGS INC.

CBSTF

MAPS

MJUS

MSOS

AdvisorShares Trust AdvisorShares MSOS 2x Daily ETF

MSOX

TLRY

TRUL

WEED

YOLO

CSE:TRUL

TSX:WEED

The cannabis sector saw a notable upswing on Tuesday on news of the Drug Enforcement Administration&#39;s (DEA) historic decision to align its stance with a recommendation from the Department of Health and Human Services and move 

Cannabis Stocks And ETFs Surge As DEA Moves To Reschedule Marijuana

Charles River (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRL#NYSE">CRL</a>) underwent analysis by 10 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
<table>
<thead>
<tr>
<th></th>
<th style="text-align: right;">Bullish</th>
<th style="text-align: right;">Somewhat Bullish</th>
<th style="text-align: right;">Indifferent</th>
<th style="text-align: right;">Somewhat Bearish</th>
<th style="text-align: right;">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">6</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td style="text-align: right;">2</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">4</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">1</td>
<td style="text-align: right;">0</td>
<td style="text-align: right;">0</td>
</tr>
</tbody>
</table>
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $218.3, with a high estimate of $250.00 and a low estimate of $190.00. Observing a downward trend, the current average is 13.6% lower than the prior average price target of $252.67. 
<img src="https://www.benzinga.com/files/images/story/2024/1726833616_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The perception of Charles River by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Eric Coldwell</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$190.00</td>
<td>$191.00</td>
</tr>
<tr>
<td>Charles Rhyee</td>
<td>TD Cowen</td>
<td>Lowers</td>
<td>Hold</td>
<td>$203.00</td>
<td>$228.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$210.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>Dan Brennan</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$240.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Ross Muken</td>
<td>Evercore ISI Group</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$225.00</td>
<td>$265.00</td>
</tr>
<tr>
<td>Matthew Sykes</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$250.00</td>
<td>$290.00</td>
</tr>
<tr>
<td>Casey Woodring</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$205.00</td>
<td>$270.00</td>
</tr>
<tr>
<td>Eric Coldwell</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$191.00</td>
<td>$239.00</td>
</tr>
<tr>
<td>Eric Coldwell</td>
<td>Baird</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$239.00</td>
<td>$271.00</td>
</tr>
<tr>
<td>Luke Sergott</td>
<td>Barclays</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$230.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Charles River. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Charles River compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Charles River's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Charles River's market position. Stay informed and make well-informed decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/CRL/analyst-ratings?utm_source=Benzinga Insights">Stay up to date on Charles River analyst ratings.</a>
<h2>Get to Know Charles River Better</h2>
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model &amp; services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery &amp; safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
<h3>Charles River: Delving into Financials</h3>
Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.
Revenue Challenges: Charles River's revenue growth over 3 months faced difficulties. As of 30 June, 2024, the company experienced a decline of approximately -3.19%. This indicates a decrease in top-line earnings. When compared to others in the Health Care sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Charles River's net margin excels beyond industry benchmarks, reaching 8.77%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Charles River's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.44%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.12%, the company showcases effective utilization of assets.
Debt Management: Charles River's debt-to-equity ratio is below the industry average at 0.76, reflecting a lower dependency on debt financing and a more conservative financial approach.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;utm_source=benzinga-insights">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

The Analyst Verdict: Charles River In The Eyes Of 10 Experts

The Federal Reserve announced Wednesday<a href="https://www.benzinga.com/economics/macro-economic-events/24/09/40926026/federal-reserve-delivers-bold-0-5-rate-cut-signals-further-easing-ahead"> a deep 50 basis-point cut to its Fed funds rate, </a>which is likely to ease the pressure on consumers. An analyst, however, sees a return of recession along with stagnation.
What Happened: &#8220;Get ready for stagnation,&#8221; said GLJ Research&#8217;s Gordon Johnson, adding that, this is the &#8220;inflation is Transitory&#8221; mistake all over again. To make his case, he noted four corporate announcements suggesting the near could be challenging.
China Drags Skechers: Skechers U.S.A., Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SKX#NYSE">SKX</a>), which designs, manufactures and distributes footwear, sees softness in China&#8217;s business. CFO John Vandemore said, at the Wells Fargo Consumer Conference, &#8220;We've definitely seen worse conditions unfold in China than we expected for the back half of the year, so I would expect the back of the year's going to be more disappointing than what we had originally thought.&#8221; The shares reacted with a sharp tumble on Thursday, settling down 9.62% to $61.56
Rough Road For Mercedes-Benz: Also German automaker Mercedes-Benz Group AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MBGAF#OTC">MBGAF</a>) late Thursday said its 2024 earnings before interest and taxes will likely come in &#8220;significantly below&#8221; the previous year, citing a further deterioration in the macroeconomic environment, mainly in China. The automaker also said it expects its adjusted return on sales to be between 7.5% and 8.5%, down from its earlier forecast of 10% to 11%. The company&#8217;s shares listed on the Frankfurt exchange fell nearly 7%.
See Also: <a href="https://www.benzinga.com/money/best-depression-stocks">Best Depression Stocks</a>
FedEx Doesn&#8217;t Deliver: Package-shipping company FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) reported first-quarter earnings that fell year-over-year and missed expectations. The company reduced the high end of the full-year adjusted operating income guidance. The predicament was blamed on circumspect consumers favoring cheaper services over pricey and speedier options. The stock fell over 13% in premarket trading on Friday.
Lennar&#8217;s Underwhelming Quarter: Homebuilder Lennar Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEN#NYSE">LEN</a>) reported roughly 8% revenue growth to $9.42 billion and earnings per share were up 10% but the average sales price of houses fell.
More Cuts At Warner Music: Entertainment and record-label company Warner Music Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) said Thursday it plans to reduce its workforce by about 750 employees, representing 13% of its total headcount, more than the 10% expected earlier.
R-Word Still Floats Around: Chief Global Strategist of BCA Research Peter Berezin said in an X post that the 50 basis-point cut and another 50 bps reduction the central bank is penciling in before the year-end <a href="https://www.benzinga.com/news/earnings/24/09/40954521/wall-street-looks-to-pause-after-s-ps-record-performance-as-fed-rate-cut-euphoria-fades-and-hard-la">may not ensure a soft landing. </a>He pointed out to the previous two rate-cut cycles when recession followed following 100 basis-point cuts.
The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>), an exchange-traded fund that tracks the S&amp;P 500 Index, fell 0.26% to $567.76, according to <a href="https://benzinga.grsm.io/register174">Benzinga Pro data. </a>The ETF, however, is up nearly 21% so far this year.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40948046/fedex-q1-earnings-revenue-miss-eps-miss-lowered-guidance-challenging-quarter">FedEx Q1 Earnings: Revenue Miss, EPS Miss, Lowered Guidance — &#8216;Challenging Quarter&#8217;</a></li>
</ul>
Image Via Shutterstock

Earnings

Equities

Economics

MERCEDES BENZ GROUP AG by Mercedes Benz Group AG

MBGAF

Brace For Stagflation After Fed's Benevolence, Warns Analyst, Raising 5 Corporate Red Flags: 'Inflation Is Transitory Mistake All Over Again'

Evercore ISI Group analyst Greg Melich maintains AutoZone (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZO#NYSE">AZO</a>) with a Outperform and lowers the price target from $3900 to $3350.

Price Target

Evercore ISI Group Maintains Outperform on AutoZone, Lowers Price Target to $3350

As of Sept. 20, 2024, two stocks in the energy sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi">RSI is above 70</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>. 
Here's the latest list of major overbought players in this sector.
<h3 class="wp-block-heading">Brooge Energy Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BROG#NASDAQ">BROG</a>)</h3>
<ul>
<li>On June 5, Brooge Energy announced the receipt of Nasdaq non-compliance letter. The company's stock gained around 82% over the past month and has a <a href="https://www.benzinga.com/quote/BROG">52-week high of $6.66</a>.</li>
<li>RSI Value: 83.55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>BROG Price Action: Shares of Brooge Energy gained 14.9% to close at $1.77 on Thursday.</li>
</ul>
<h3 class="wp-block-heading">Battalion Oil Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BATL#NYSE">BATL</a>)</h3>
<ul>
<li>On Sept. 19, Battalion Oil announced it has amended its merger agreement with Fury Resources for the acquisition of all outstanding shares of Battalion at $7.00 per share in cash. Avi Mirman, Co-Founder and Chairman of Fury Resources stated "With this acquisition, Fury has secured a foothold in one of the world&#8217;s most prolific basins. Our team has significant experience in the region, and we believe these assets present a compelling value proposition for our investors. With a deep inventory of high return locations and consolidation opportunities in the area, we believe this asset can be scaled quickly and provide a meaningful return to our investors. We have strong institutional support for this transaction, including the Rollover Stockholders. We view their decision to stay in the investment opportunity as a strong vote of confidence in our ability to deliver results and are excited for us to get to work." The company's stock gained around 17% over the past month and <a href="https://www.benzinga.com/quote/BATL">has a 52-week high</a> of $9.69.</li>
<li>RSI Value: 83.48</li>
<li>BATL Price Action: Shares of Battalion Oil fell 3.6% to close at $2.94 on Thursday. </li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40952252/nvidia-tesla-rally-as-dow-s-p-500-surge-to-fresh-highs-after-fed-cuts-rates-fear-index-remains-in-g">Nvidia, Tesla Rally As Dow, S&amp;P 500 Surge To Fresh Highs After Fed Cuts Rates: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Short Ideas

Pre-Market Outlook

BATL

BROG

Top 2 Energy Stocks That May Collapse In Q3

The Federal Reserve surprised investors earlier this week by enacting an aggressive 50 basis point cut in benchmark interest rates, marking the first such move since March 2020.
What happened: The dip in borrowing costs immediately boosted risky asset classes like cryptocurrencies, with Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) spiking 7.7% since the announcement.
The rate was <a href="https://www.federalreserve.gov/newsevents/pressreleases/monetary20200315b.htm">last slashed in an emergency meeting</a> on March 15, 2020, in reaction to the risk posed by the COVID-19 pandemic to the U.S. economy. The federal funds rate was lowered to the range of 0%-0.25%.
At that time, one Bitcoin was priced at $5,392.31. Accordingly, an investment of $1,000 would have fetched you 0.1854 units of the world's largest cryptocurrency. 
Today, the price of one Bitcoin has ballooned to $63,797.59, meaning that 0.1854 BTCs would be worth $11,831.21, marking a whopping 1083% return.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40950912/bitcoins-reserve-asset-appeal-increased-due-to-state-of-us-federal-deficit-and-debt-says-b">Bitcoin&#8217;s Reserve Asset Appeal Increased Due To State Of US Federal Deficit And Debt, Says BlackRock: A Hedge Against &#8216;Possible Future Events&#8217; Affecting The Dollar</a>
Why It Matters: Bitcoin, along with the broader cryptocurrency market, <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40945629/bitcoin-could-surge-after-interest-rate-cut-as-macro-drivers-take-over-standard-chartered">was expected to witness substantial upsides</a> following the bold reduction in interest rates, according to British multinational bank Standard Chartered.
Other noted macro analysts like Alex Kruger have also issued bullish forecasts for the leading cryptocurrency, <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40942948/what-does-the-feds-interest-rate-cut-mean-for-bitcoin-50-bps-cut-is-the-sweet-spot-says-ma">calling the 50-basis point cut a "sweet spot.</a>"
Price Action: At the time of writing, Bitcoin was exchanging hands at $63,731.27, up 2.83% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.&nbsp;
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40951267/max-keiser-attacks-michael-saylor-for-finding-fault-with-el-salvadors-bitcoin-strategy-you">Max Keiser Attacks Michael Saylor For Finding Fault With El Salvador&#8217;s Bitcoin Strategy: &#8216;You Owe Nayib Bukele An Apology&#8217;</a></li>
</ul>

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$BTC

If You Invested $1000 in Bitcoin When The Fed Last Cut Interest Rates, Here's How Much It'd Be Worth Today

B of A Securities analyst Ross Fowler reinstates American Water Works (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AWK#NYSE">AWK</a>) with a Underperform and announces $140 price target.

Initiation

B of A Securities Reinstates Underperform on American Water Works, Announces $140 Price Target

A new analysis suggests that Bitcoin&#8216;s (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) correction phase may have come to an end, with experts now predicting a potential <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40926729/bitcoin-spikes-above-61-000-as-fed-implements-50-bps-rate-cut">surge towards the $70,000 mark</a>.
What Happened: According to a 10x Research report, trading signals have increased long positions to 70% net long for the first time, indicating a favorable buying opportunity for both Bitcoin and Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>) with a 2-3 month horizon.
The report highlights that weekly reversal indicators are showing signs of bottoming out for the first time since the correction began in March, signaling a more positive outlook for the leading cryptocurrency.
Bitcoin&#8217;s weekly Relative Strength Index (RSI) is attempting to establish a medium-term low at 50%, further supporting the bullish sentiment. Key support levels are identified at $52,599 and $56,000, with resistance at $64,490. 
Analysts suggest that a break above the August short-term high of $64,490 could propel Bitcoin toward $70,000 or beyond.
The recent <a href="https://www.benzinga.com/markets/asia/24/09/40951221/bank-of-japan-leaves-interest-rate-at-0-25-diverging-from-feds-50-basis-point-cut">50 basis point rate cut</a> by the Federal Reserve has added an interesting dynamic to the market.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/events/digital-assets/ "><img loading="lazy" decoding="async" width="300" height="250" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/03/29155259/905735A6-57D3-4874-9AA1-75D037842DB3-2.gif" alt="Benzinga Future of Digital Assets conference" class="wp-image-270548" /></a></figure>
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40945847/donald-trump-now-trails-kamala-harris-by-4-points-after-9-point-election-odds-turnaround-i">Donald Trump Now Trails Kamala Harris By 4 Points After 9-Point Election Odds Turnaround In Only 9 Days</a>
While historically, such cuts have led to short-term rallies in Bitcoin, lasting 1-2 weeks, the long-term impact remains to be seen. 
Fed Chair Powell&#8217;s cautious framing of the rate cut has left room for interpretation regarding the broader economic outlook.
Interestingly, funding rates for Bitcoin and Ether have returned to double digits, indicating significant bets from futures traders. 
This renewed momentum is primarily driven by activity in the futures market, with rising trading volumes in Korea suggesting increased participation from retail investors.
What&#8217;s Next: As the cryptocurrency market enters the historically bullish fourth quarter, many eyes will be on Benzinga&#8217;s <a href="https://www.benzinga.com/events/digital-assets/agenda/">Future of Digital Assets</a> event on Nov. 19.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/09/40945629/bitcoin-could-surge-after-interest-rate-cut-as-macro-drivers-take-over-standard-chartered">Bitcoin Could Surge After Interest Rate Cut As Macro Drivers Take Over: Standard Chartered</a></li>
</ul>

$ETH

Bitcoin's Correction Ends, But It Has To Break This Target To Surge To $70K: 10x Research

B of A Securities analyst Ross Fowler reinstates Essential Utilities (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTRG#NYSE">WTRG</a>) with a Buy and announces $45 price target.

WTRG

B of A Securities Reinstates Buy on Essential Utilities, Announces $45 Price Target

WIIM

AEMD

Aethlon Medical shares are trading higher after the company announced that it received granted ethics committee approval for Hemopurifier cancer treatment. Also, the European Commission recommended extending the indication of the smallpox and mpox vaccine to adolescents.

B of A Securities analyst Ross Fowler initiates coverage on SJW Gr (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SJW#NYSE">SJW</a>) with a Neutral rating and announces Price Target of $65.

B of A Securities Initiates Coverage On SJW Gr with Neutral Rating, Announces Price Target of $65

Biotech

Large Cap

Health Care

REGN

The European Medicines Agency's Committee For Medicinal Products For Human Use Adopted A Positive Opinion Recommending The Expanded Approval Of Regeneron Pharmaceuticals/Sanofi's Dupixent (Dupilumab) For Eosinophilic Esophagitis In Children Down To 1 Year Of Age

Arq shares are trading lower after the company announced a proposed public offering of common stock, details not disclosed.

GNFT

GENFIT shares are trading higher. The company reported H1 financial results.

KOPN

Kopin shares are trading lower after the company announced a public offering of common stock and pre-funded warrants, size not disclosed.

Thor Industries, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/THO#NYSE">THO</a>) will release earnings results for its fiscal 2024 fourth quarter, before the <a href="https://www.benzinga.com/quote/THO/earnings">opening bell on Tuesday, Sept. 24.</a>
Analysts expect the company to report quarterly earnings at $4.83 per share, up from $4.55 per share in the year-ago period. Thor Industries projects to report revenue of $21.99 billion for the quarter, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On June 19, THOR Industries said its Board of Directors approved the payment of a regular quarterly cash dividend of 48 cents per share.
Thor Industries shares fell 0.5% to close at $188.43 on Wednesday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/TJX/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/6531555b0d10db0001eaba63/tristan-thomas-martin">BMO Capital analyst Tristan Thomas-Martin</a> maintained an Outperform rating with a price target of $120 on Sept. 19. This analyst has an accuracy rate of 60%.</li>
<li>Citigroup analyst James Hardiman maintained a Buy rating and slashed the price target from $120 to $113 on June 7. This analyst has an accuracy rate of 68%.</li>
<li><a href="https://www.benzinga.com/analyst-stock-ratings/analyst/58ee65320bd9910001ca9bef/michael-swartz">Truist Securities analyst Michael Swartz</a> maintained a Hold rating and cut the price target from $100 to $95 on June 6. This analyst has an accuracy rate of 70%.</li>
<li>Baird analyst Craig Kennison maintained an Outperform rating and slashed the price target from $120 to $110 on June 6. This analyst has an accuracy rate of 67%.</li>
</ul>
Considering buying THO stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="511" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156-1024x511.png" alt="" class="wp-image-557627" style="width:635px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156-1024x511.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156-768x383.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/09/20022246/image-156.png 1326w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/24/09/40948972/coinbase-global-electronic-arts-and-2-other-stocks-executives-are-selling">Coinbase Global, Electronic Arts And 2 Other Stocks Executives Are Selling</a></li>
</ul>

Thor Industries Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.
When insiders purchase shares, it indicates their confidence in the company&#8217;s prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
Below is a look at a few recent notable insider purchases. For more, check out <a href="https://www.benzinga.com/sec/insider-trades/">Benzinga&#8217;s insider transactions</a> platform.
<h3 class="wp-block-heading">Middlefield Banc</h3>
<ul>
<li>The Trade: Middlefield Banc Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MBCN#NASDAQ">MBCN</a>) CEO Ronald Len. Zimmerly Jr <a href="https://www.benzinga.com/quote/ONEW/analyst-ratings">acquired a total of 1,000 shares at</a> an average price of $22.47. To acquire these shares, it cost around $22,470.</li>
<li>What's Happening: On July 18, Middlefield Banc reported quarterly earnings of 52 cents per share which beat the analyst consensus estimate of 40 cents per share.</li>
<li>What Middlefield Banc Does: Middlefield Banc Corp is a United States-based bank holding company.</li>
</ul>

<h3 class="wp-block-heading">Focus Universal</h3>
<ul>
<li>The Trade: Focus Universal Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FCUV#NASDAQ">FCUV</a>) Director Edward Shihai Lee acquired a total of 1,000,000 shares at an average price of $0.30. To acquire these shares, it cost around $300,000.</li>
<li>What's Happening: On Sept. 16, Focus Universal announced a $1.2 million registered direct offering of 3.75 million shares at $0.32 per share.</li>
<li>What Focus Universal Does: Focus Universal Inc develops and manufactures universal smart devices.</li>
</ul>
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/24/09/40952252/nvidia-tesla-rally-as-dow-s-p-500-surge-to-fresh-highs-after-fed-cuts-rates-fear-index-remains-in-g">Nvidia, Tesla Rally As Dow, S&amp;P 500 Surge To Fresh Highs After Fed Cuts Rates: Fear Index Remains In &#8216;Greed&#8217; Zone</a></li>
</ul>

Long Ideas

Insider Trades

FCUV

MBCN

Executives Buying Middlefield Banc And 1 Other Stock

TNON

Tenon Medical shares are trading higher after the company announced the issuance of three notices of allowance for patent applications from the UPSTO.

Battalion Oil Corp shares are trading higher after the company announced it has amended its merger agreement with Fury Resources for the acquisition of all outstanding shares of Battalion at $7.00 per share in cash.

MTDR

Matador Resources Says It Intends To Offer $750M Of Senior Unsecured Notes Due 2033 In A Private Placement To Eligible Purchasers; Company Will Use Net Proceeds From The Offering To Repay Borrowings Outstanding Under Credit Facility

United Parcel Service shares are trading lower in sympathy with FedEx which reported worse-than-expected Q1 financial results and cut its FY25 guidance.

The past, present and future of the Canadian cannabis sector.

The Canadian Cannabis Report- Monday, Aug 12

Opportunities In The Evolving Cannabis Consumption Market

Poll shows support for marijuana legalization, cannabis banking in swing states

The past, present, and future of the Canadian cannabis sector based on the performance of the MCCCI, which is a proprietary index of 14 stocks.

The Canadian Cannabis Report - Monday Aug. 19

Marijuana rescheduling likely delayed due to DEA hearing

There was a 1.6% increase in the relative strength index compared to the prior week when there was a 6.9 % increase. 2 of the 14 MCCCI stocks increased. 

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Get Our Top Trade Ideas Delivered Daily - 65% Off Now

Comments

Amplify Seymour Cannabis ETF

Overview

Amplify Seymour Cannabis ETF (ARCA:CNBS), Quote.Headers.trade-ideas